Printer Friendly

GENSIA ANNOUNCES THREE-FOR-TWO STOCK SPLIT

 GENSIA ANNOUNCES THREE-FOR-TWO STOCK SPLIT
 SAN DIEGO, Jan. 31 /PRNewswire/ -- Gensia Pharmaceuticals Inc.


(NASDAQ: GNSA) today announced a three-for-two stock split in the form of a stock dividend, payable to stockholders of record as of Feb. 10, 1992.
 Gensia stockholders of record at the close of business on Feb. 10, 1992 will receive certificates representing one additional share for each two shares of common stock held at that time. The additional shares are expected to be delivered to eligible shareholders on or about March 2, 1992. Fractional shares will be paid in cash based on the closing price of Gensia common stock on the record date.
 According to David F. Hale, Gensia chairman, president and chief executive officer, "We view this stock split as the proper step to take at this time toward establishing a broader market in Gensia common stock."
 Gensia Pharmaceuticals is a San Diego-based biopharmaceutical company formed to discover, develop, manufacture and market novel pharmaceutical products for the treatment and diagnosis of human diseases. Gensia currently has two cardiovascular drugs in late-stage clinical trials, Arasine (TM) and arbutamine, part of the GenESA (TM) System.
 -0- 1/31/92
 /CONTACT: David F. Hale and Martha L. Hough of Gensia Pharmaceuticals Inc., 619-546-8300/
 (GNSA) CO: Gensia Pharmaceuticals ST: California IN: MTC SU:


DM-EH -- SD001 -- 5501 01/31/92 09:15 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 31, 1992
Words:222
Previous Article:SURETY CAPITAL CORPORATION ANNOUNCES ANNUAL RESULTS
Next Article:VIKONICS ANNOUNCES KUWAIT DISTRIBUTION AGREEMENT
Topics:


Related Articles
UNDERWRITERS' OPTION EXERCISED IN ARAMED UNIT OFFERING AND GENSIA COMMON STOCK OFFERING
GENSIA REPORTS 1992 SECOND QUARTER RESULTS
GENSIA ANNOUNCES DETAILS ON CVR PAYMENT
Gensia Announces Private Placement of Common Stock
Gensia Sicor Announces Private Placement of Units
Gensia Sicor Completes Private Placement of $20 Million in Convertible Notes and Warrants
Gensia Sicor Announces Private Placement of Units; Sale of Land in San Diego
Gensia Sicor Files Form S-3 Registration Statement for Previously Announced Private Placements
Gensia Sicor Announces Private Placement of Units and Declares Quarterly Dividend.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters